Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Subcontract Opportunity Decomposition Not Available

Active

Federal

Response Deadline08/10/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

A subcontract opportunity has been posted with a response deadline of August 10, 2026, and was made available on August 2, 2026, under the solicitation number SPE2DP26T4436. The opportunity is linked to the Department of Defense through the Medical Supply Chain Pharm FSA, with the place of performance located at Fort Stewart, Georgia, 31314-5185. No NAICS code has been assigned, and details regarding set-aside type, organization structure, or point of contact are not available. The full breakdown of subcontract requirements and supplier qualifications cannot be accessed due to a system configuration error, limiting visibility into specific work scope or eligibility criteria. Interested parties must reference the provided DIBBS link for further information, though critical data necessary for bid preparation remains undefined.

General Info

Subcontract opportunity under DOD solicitation SPE2DP26T4436 due August 10, 2026, at Fort Stewart, Georgia.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

Place of Performance

FORT STEWART, GA, 31314-5185, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 2

subcontract

Response DeadlineAug 10

Submission deadline

Response Deadline

08/10/2026, 05:00:00 PM UTCin 7 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Contract details could not be retrieved due to a system configuration error. Subcontract and supplier opportunities cannot be identified at this time.

Similar Contracts

Same NAICS industry code

Unable to Retrieve Subcontract OpportunitiesThe contract opportunity titled "Unable to Retrieve Subcontract Opportunities" was posted on August 3, 2026, with a response deadline set for September 2, 2026. It is classified as a subcontract under a Total Small Business Set-Aside, meaning only small businesses are eligible to compete, as defined by the Small Business Administration and FAR 19.5. The solicitation number SPE4A726R0674 is associated with this opportunity, which is managed by the ASC SUPPLIER OPER AE AND AF DIV under the Department of Defense. However, critical details including the NAICS code, place of performance, point of contact, and the prime contract context are unavailable due to a system timeout. The location, agency office address, and specific performance requirements cannot be determined from the provided data, and no further decomposition or subcontracting structure can be identified at this time. Interested parties are directed to the provided UI link for potential updates or additional information.

ASC SUPPLIER OPER AE AND AF DIV

POSTED

about 11 hours ago

DEADLINE

Data Not AvailableNo valid prime contract data was found to decompose into subcontract opportunities, and the provided document is a general aviation source approval and management handbook rather than a specific contract award or solicitation. The record indicates a posted date of August 3, 2026, with a response deadline of August 7, 2026, and classifies the opportunity as a subcontract under the Department of Defense’s DLA Aviation, with a place of performance in Richmond, Virginia, zip code 23237. No solicitation number,NAICS code, type of set aside, or point of contact is available, and the organizational details, including office address and agency type, are incomplete or unspecified. The linked SAM.gov page does not contain actionable procurement data for subcontracting purposes.

POSTED

about 16 hours ago

DEADLINE

Data Unavailable Due to System ErrorThe contract pertains to a subcontract opportunity under the Nuclear Reactor Program managed by the Department of Defense, with a posted date of August 2, 2026, and a response deadline of August 13, 2026. The place of performance is designated as Robins AFB, Georgia, with a zip code of 31098-1887, though no specific city or state details are provided beyond that. The solicitation number is SPE7M226T5948, and the NAICS code is listed as NA, indicating that the specific industry classification is unavailable. No set-aside type or organization type is specified, and no point of contact information is available. While the system was unable to retrieve detailed prime contract information, the subcontract opportunity remains active with a clear deadline and public link for access.

NUCLEAR REACTOR PROGRAM

POSTED

DEADLINE

Unable to Retrieve Subcontract OpportunitiesNo subcontract opportunities are available due to a configuration error that blocks access to the prime contract data, preventing any identification of potential subcontracting roles. The solicitation, posted on August 2, 2026, with a response deadline of August 13, 2026, is categorized as a subcontract under the ACTIVE DEVICES DIVISION within the Department of Defense, though no NAICS code, set-aside type, or organizational details are provided. The place of performance is listed as New Cumberland with a zip code of 17070-5002, but no office address or point of contact information is available. The only accessible detail is the UI link directing to the DIBBS platform for further inquiry, though the underlying contract data remains inaccessible.

ACTIVE DEVICES DIVISION

POSTED

DEADLINE

Subcontract Opportunity Decomposition UnavailableA subcontract opportunity has been posted under the Aviation Supply Chain division of the Department of Defense with a posting date of August 2, 2026, and a response deadline of August 10, 2026. The solicitation number is unavailable, and the North American Industry Classification System code is listed as NA, indicating incomplete or unassigned industry classification. No set-aside type or description is provided, and details regarding the organization type and point of contact are missing. The place of performance is listed as FPO with a ZIP code of 96672, suggesting a military post office location. The prime contract details could not be retrieved due to a configuration error, which has prevented the decomposition of the opportunity into any sub-opportunities. The procurement is accessible through a public link on the DIBBS system, but no further procedural or technical specifications are available within the provided data.

AVIATION SUPPLY CHAIN

POSTED

DEADLINE

Data Unavailable Due to System OutageThe contract titled "Data Unavailable Due to System Outage" was posted on August 2, 2026, with a response deadline of August 10, 2026, and is classified as a subcontract under the Department of Defense’s Medical Supply Chain FSH. The place of performance is listed as FPO with a zip code of 09583-0200, though no specific city, state, or country details are provided. The NAICS code is listed as NA, and no set-aside type or organization type is specified. The solicitation number is SPE2DH26T5729, and while a UI link is included for reference, no prime contract details, scope of work, or subcontract opportunities are currently accessible due to a system timeout. No point of contact information is available.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Insufficient Data to Identify Sub-OpportunitiesThe contract solicitation titled "Insufficient Data to Identify Sub-Opportunities" was posted on August 2, 2026, with a response deadline of August 13, 2026, and is categorized as a subcontract under the Department of Defense. No complete Statement of Work, scope details, or sufficient CLIN data are available to define viable subcontract or supplier opportunities. Only one partial CLIN, 'TIE DOWN, CARGO, VEH1', has been identified, which lacks the necessary detail to extract meaningful sub-tasks or establish deliverables. The place of performance is listed as New Cumberland, Pennsylvania, with a zip code of 17070-5002, but no specific organizational type, set-aside information, or point of contact is provided. The NAICS code is listed as NA, and no office address or point of contact details are included, limiting the ability to assess requirements or engage potential vendors meaningfully.

CONSTRUCTION & EQUIPMENT MANU & CON

POSTED

DEADLINE

Subcontract Opportunity Decomposition UnavailableThe subcontract opportunity dated August 2, 2026, with a response deadline of August 10, 2026, is associated with the Department of Defense through the Medical Supply Chain Pharm FSA. The solicitation number is SPE2DP26T4447, and the opportunity is listed as a subcontract with no set-aside classification or NAICS code provided. Details regarding the prime contract, point of contact, place of performance, and organizational type could not be retrieved due to a configuration error, which also prevents the decomposition of potential subcontract and supplier opportunities. The official UI link is available for further reference but does not contain additional contractual specifics beyond the posted dates and agency information.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Unable to decompose sub-opportunities due to system configuration errorThe contract notice outlines a system configuration error that prevents the identification and decomposition of subcontract opportunities, rendering the prime contract details inaccessible due to a missing FOUNDRY_API_URL setting. As a result, no subcontract opportunities can be structured or pursued, despite the posting of a solicitation with a title indicating the technical limitation. The notice was posted on August 2, 2026, with a response deadline of August 10, 2026, and is categorized as a subcontract under the Department of Defense’s ASC Commodities Division. The place of performance is listed as New Cumberland, Pennsylvania, with a zip code of 17070-5002, while all other geographical and organizational details remain unspecified. The NAICS code is marked as NA, and no set-aside type, point of contact, or agency address information is provided. The only actionable reference is the DIBBS solicitation link for further inquiries.

ASC COMMODITIES DIVISION

POSTED

DEADLINE

Subcontract Opportunity Decomposition Not AvailableThe subcontract opportunity decomposition is not available due to a configuration error that prevented access to the underlying prime contract, making it impossible to identify or analyze any related sub-opportunities. The solicitation is tied to the Defense Logistics Agency under the Department of Defense, with a posted date of August 2, 2026, and a reference to contract SPE7M117D0001 and delivery SPE7LX26F86G0, but no solicitation number, NAICS code, set-aside details, organizational type, or point of contact information has been provided. The place of performance and office address fields are all blank, and the only accessible identifier is a URL linking to a DIBBS record, with no further details available to determine scope, requirements, or eligibility criteria.

Defense Logistics Agency

POSTED

DEADLINE

Subcontract Opportunity Decomposition Not AvailableThe subcontract opportunity associated with Solicitation Number SPE2DX25D8022 and Delivery Order SPE2D926F7842 is listed under the Defense Logistics Agency within the Department of Defense, with a posted date of August 2, 2026. However, critical details including the prime contract information, NAICS code, set-aside type, organizational structure, and point of contact are unavailable due to a configuration error that prevents system decomposition of the opportunity into subcontract components. The place of performance and office address fields are undefined, and no specific city, state, or zip code information is provided. The public portal link directs to the DIBBS system for potential further inquiry, but the full scope, requirements, and eligibility criteria for this subcontract opportunity remain inaccessible due to missing data and system limitations.

Defense Logistics Agency

POSTED

DEADLINE

Unable to Decompose Subcontract OpportunitiesA configuration error has prevented access to the prime contract details, including the Statement of Work, CLINs, agency-specific information, and NAICS code, rendering it impossible to decompose the contract into subcontract or supplier opportunities. Despite this, the solicitation is listed under the Defense Logistics Agency within the Department of Defense, with a posted date of August 2, 2026, and a response deadline of August 13, 2026. The contract type is classified as a subcontract, but no set-aside designation is available, and the place of performance is indicated as FPO with a ZIP code of 09573. The official UI link is provided for further reference, though critical data required for meaningful participation or analysis remains unavailable due to the technical misconfiguration.

Defense Logistics Agency

POSTED

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

GABAPENTIN CAPSULES

Solicitation # SPE2DP-26-T-4457

GABAPENTIN CAPSULES, 100 MG in units of 100s, are procured under solicitation SPE2DP-26-T-4457 with a total requirement of 7,000 capsules across two line items, each with a 0% quantity variance. The item is regulated by the FDA and must comply with the DLA Master List of Technical and Quality Requirements, including shelf-life specifications of 36 months non-extendable for TYPE I (CODE Q) items. Packaging must meet Commercial standards and Medical Marking Standard No. 1, superseding MIL-STD-129, with all labeling and palletization aligned to RP001 and DLA packaging directives. Storage must maintain 25°C (77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F) per USP Controlled Room Temperature. The material is not classified as hazardous under FED-STD-313 and must be commercially packaged in accordance with ASTM D3951, though DLA requirements override any conflicting standards. Delivery is FOB destination with a five-day lead time and inspection and acceptance occurring at the destination point. The items are to be shipped via traceable means, not parcel post, to the USS MAKIN ISLAND LHD 8 at FPO AP 96672, with a required delivery date of April 3, 2026. Manufacturers include MARLEX PHARMACEUTICALS INC, CIPLA USA INC, and SCIEGEN PHARMACEUTICALS INC, identified by their respective NDC codes. The unit of issue is BT (100s), with each unit pack containing one BT. All packaging and marking must reflect the correct NSN 6505013871892, and vendors must use the DLA VSM system for shipment tracking. Government use codes and contract identifiers are specified for administrative and logistical tracking, and all documentation must adhere to the latest DLA procedural notes for transportation, marking, and delivery verification.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

TOLNAFTATE POWDER, U

Solicitation # SPE2DP-26-T-4452

The contract specifies the procurement of Tolnaftate Powder, USP 1%, in 45-gram units, with a total quantity of 19 BT (each BT equaling 45 grams), supplied by Geri-Care Pharmaceuticals Corp. under part number NDC57896-0199-45 and NSN 6505014807897. Delivery is required within five days FOB destination, with no variance allowed in quantity, and inspection and acceptance occur at the delivery point. The product must comply with strict packaging and marking standards, including Medical Marking Standard No. 1, which replaces all references to MIL-STD-129, and must be packed in sealed unit containers and commercial shipping containers ensuring safe transport at the lowest carrier rate. The item is classified as a TYPE I (CODE Q) medical product with a non-extendable shelf life of 36 months. All packaging and labeling must adhere to DLA requirements outlined in the Master List of Technical and Quality Requirements, and covered defense information protocols apply. The solicitation, issued under SPE2DP-26-T-4452 with a response deadline of August 10, 2026, is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with point of contact Imerah Burnett at Offutt AFB, and the unit of issue follows DoD authorization with corresponding ANSI X12 alignment.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

LIDOCAINE HYDROCHLORID

Solicitation # SPE2DP-26-T-4454

Lidocaine hydrochloride and dextrose injection in 500 mL premixed bags, containing 0.4% lidocaine and 5% dextrose, is being procured under solicitation SPE2DP-26-T-4454 with a unit of issue defined as a package of 18 bags. The item must meet stringent technical and quality standards outlined in the DLA Master List of Technical and Quality Requirements, and packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129. At least 16 months of shelf life must remain at the time of delivery to the first government activity, as the product has a fixed 18-month non-extendable shelf life under Type I (Code K) requirements. The drug is regulated by the FDA, and contractors must ensure full compliance with all applicable federal standards for commercial packaging, including ASTM D3951 where applicable, though DLA requirements take precedence. The product is currently in limited supply due to manufacturing constraints, and only Baxter Healthcare Corp’s specific NDC 00338-0409-03 and part number 2B0973P are authorized. Delivery is required within five days of award, FOB destination, with zero variance permitted in quantity. The shipment must be sent via traceable and expedited means to the USS THEODORE ROOSEVELT CVN 71 at FPO AP 96632, using RDD 777 and VSM logistics protocols, and parcel post is strictly prohibited. Packaging must be palletized according to RP001 requirements and labeled in full compliance with DLA’s medical marking standards. The contract specifies a single purchase request quantity of one package, with a required delivery date of August 5, 2026, and procurement is managed by the Department of Defense’s Medical Supply Chain PHARM FSA. All bidders must provide detailed manufacturer and product information for FDA verification through EBS referral prior to award.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

SODIUM CHLORIDE IRRIGA

Solicitation # SPE2DP-26-T-4449

Sodium Chloride Irrigation, USP, is prescribed as a 0.9% solution in 250 mL plastic squeeze bottles, packaged 24 bottles per packing group, and must be stored at controlled room temperature of 25 degrees Celsius with protection from excessive heat. The product must comply with the DLA Master List of Technical and Quality Requirements, and its shelf life is fixed at 36 months without extension, classified as a Type I (Code Q) item. All packaging and labeling must adhere strictly to Medical Marking Standard No. 1, superseding MIL-STD-129, with documentation available via DLA Troop Support. Each unit must be sealed and protected from damage, and shipped in commercial exterior containers suitable for safe delivery by common carrier at the lowest cost to the designated destination. The item is identified by NSN 6505-01-253-8150 and NDC 00338-0048-02, supplied by Baxter Healthcare Corp, and is subject to a firm fixed price with zero variance allowed in quantity. Delivery is required FOB destination within five days of contract award, with inspection and acceptance occurring at the point of delivery. The contract is issued under solicitation SPE2DP-26-T-4449, with a response deadline of August 10, 2026, and falls under NAICS code 325412 for pharmaceutical preparation manufacturing. All data, including point of contact James Foggie and delivery location at Fort Bragg, NC, is governed by Federal procurement standards under the Department of Defense.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

BISMUTH SUBSALICYLA

Solicitation # SPE2DP-26-T-4459

The contract pertains to the procurement of Bismuth Subsalicylate Suspension, 262 mg per 15 mL, in 240 mL bottles, with a total order of two bottles. The item has a non-extendable shelf life of 24 months, and no more than 85 percent of that shelf life may have elapsed between the date of manufacture and the date of delivery to the government. Packaging must comply with commercial standards and meet the requirements of Medical Marking Standard No. 1, which supersedes MIL-STD-129; each unit must be sealed in a container that protects against damage, and all shipping containers must ensure safe, cost-effective delivery via common carrier to the designated destination. The product is regulated by the FDA and requires referral through EBS for confirmation by a product specialist, including full manufacturer and bidder details. Labeling, marking, and packaging must adhere strictly to the latest edition of Medical Marking Standard No. 1, accessible via the DLA website. Delivery is FOB destination within 20 days of contract award, with zero variance allowed in quantity, and inspection and acceptance occur at the delivery point. The item is identified by NSN 6505015056483, NDC 00536-1286-36, and is sourced from The Harvard Drug Group, L.L.C. under solicitation SPE2DP-26-T-4459, issued by the Department of Defense’s Medical Supply Chain PHARM FSA, with performance at Fort Drum, NY.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

ARTIFICIAL TEARS SOLUT

Solicitation # SPE2DP-26-T-4455

The contract specifies the procurement of 20 packages of Artificial Tears Solution, each package containing 30 single-dose vials of 0.3 mL, for a total of 600 vials. The item is regulated by the FDA and has a non-extendable shelf life of 24 months, adhering to RS001 for TYPE I (CODE M) items. Packaging must comply with the Medical Marking Standard No. 1, superseding MIL-STD-129, and all units must be hermetically sealed and protected against damage, packed in commercial shipping containers suitable for safe delivery via common carrier at the lowest cost. The product, manufactured by Allergan Inc with NDC 00023-4554-30, must be labeled and marked per DLA specifications and is not considered hazardous under Fed-Std-313, requiring commercial packaging consistent with ASTM D3951 unless superseded by higher-priority DLA technical requirements. Delivery is FOB destination within five days of order, with zero tolerance for quantity variance, and must be shipped by traceable means—parcel post is prohibited. The shipment is destined for USS THEODORE ROOSEVELT CVN 71, FPO AP 96632, with a required delivery date of August 5, 2026, and must include all applicable DLA packaging and labeling standards including palletization per RP001. The contracting official must submit an EBS referral for FDA confirmation, including manufacturer and product details.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

LIDOCAINE HYDROCHLORID

Solicitation # SPE2DP-26-T-4451

This contract specifies the procurement of 2 units of Lidocaine Hydrochloride and Epinephrine Injection, USP, each unit containing 50 cartridges of 1.7 mL with a concentration of 2% Lidocaine Hydrochloride and a 1:100,000 ratio of Epinephrine. The product is designated for local dental anesthesia via nerve block or infiltration only, must be stored at controlled room temperature below 25°C, protected from light, and must not be permitted to freeze. The item is latex-free and regulated by the FDA. A minimum of 13 months of remaining shelf life is required upon receipt by the first government activity, with a total shelf life of 15 months that is non-extendable. All packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must be suitable for commercial shipping with protection against damage and breakage. Packaging must conform to ASTM D3951 unless otherwise overridden by DLA’s Master List of Technical and Quality Requirements, and hazardous material protocols under FED-STD-313 must be followed if applicable. Units are packed as 50 cartridges per unit of issue (PG), and palletization must meet DLA’s procurement packaging standards. Delivery is required FOB destination within 20 days of contract award to Joint Base Charleston, SC, and must be shipped via traceable logistics—parcel post is prohibited. The contract is issued under solicitation SPE2DP-26-T-4451 with a response deadline of August 10, 2026, and the item’s NSN is 6505-01-597-1328. Approved manufacturers include Henry Schein, Inc., Benco Dental Supply Co., and Darby Dental Supply, LLC, with specific part and NDC numbers listed. All documentation and labeling must strictly adhere to DLA requirements and FDA regulations.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

MAGNESIUM SULFATE

Solicitation # SPE2DP-26-T-4456

MAGNESIUM SULFATE 495MG/5GM oral granules in 454GM bags, sold in cases of 12 bags each, is procured under contract SPE2DP-26-T-4456 for delivery to the USS THEODORE ROOSEVELT CVN 71 at FPO AP 96632 with a five-day delivery window and no tolerance for quantity variance. The product is classified as a TYPE I (CODE Q) medical item with a non-extendable shelf life of 36 months and must comply with Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. All packaging must meet commercial standards as specified in DLA’s procurement requirements, ensuring each unit is sealed in protective containers and packed in exterior shipping containers suitable for safe, low-cost transport by common carrier to the destination. Palletization and labeling must adhere to DLA’s Packaging Requirements for Procurement and the latest version of Medical Marking Standard No. 1, available through DLA Troop Support or their official website. The item is identified by NSN 6505-01-714-4975 and NDC 46122-0461-43, supplied by AMERISOURCEBERGEN DRUG CORP, and shipped via traceable methods only—parcel post is prohibited. Delivery is FOB destination with inspection and acceptance also occurring at the point of delivery, and the required delivery date is August 5, 2026.

Medicinal and Botanical Manufacturing

POSTED

about 11 hours ago

DEADLINE

CYCLOSPORINE OPHTHA

Solicitation # SPE2DP-26-T-4453

Cyclosporine Ophthalmic Ointment, 0.2% per gram, in a 3.5 gram sterile, preservative-free tube, is designated for veterinary use in managing keratoconjunctivitis sicca in dogs. The unit of issue is a package containing six tubes, and the product must be stored at controlled room temperature. It is subject to strict packaging standards per the latest Medical Marking Standard No. 1 and requires marking in accordance with MMS No. 1B dated 30 March 2017. The item has a non-extendable shelf life of 24 months under RS016 compliance. The product is supplied by multiple manufacturers including Merck Sharp & Dohme LLC, Patterson Veterinary Supply, Inc., and Penn Veterinary Supply Inc., each with their respective part numbers and NDC codes. This item is procured under the Department of Defense with NSN 6509-01-530-4765 and purchase request 7017723033, with a contract solicitation number SPE2DP-26-T-4453. Delivery is scheduled for 89 days after award, FOB destination, with zero variance permitted in quantity, and inspection and acceptance occur at the destination. Packaging must meet MIL-STD-2073-1E specifications, and defense information handling requirements apply. The point of contact for the solicitation is Shairy M. Cartagena at the Medical Supply Chain Pharm FSA under the DLA.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

WATER PURIFICATION TAB

Solicitation # SPE2DP-26-T-4448

The contract specifies the procurement of 200 units of water purification tablets containing stabilized chlorine dioxide, with no active chlorine or iodine, designed for military use in first aid kits. Each unit, designated as PG, contains ten individually sealed tablets and must meet a strict 60-month shelf life, with at least 51 months remaining upon delivery to the government. The product, identified by NSN 6850-01-530-3396 and part number 8014821 from KATADYN NORTH AMERICA INC., is subject to the Hazard Communication Standard as revised under OSHA’s alignment with the Globally Harmonized System, requiring suppliers to submit approved Safety Data Sheets and compliant labels prior to award, along with employee training on updated hazard communication protocols. Packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and comply with MIL-STD-2073-1E for protective sealing and shipping containers suitable for common carrier transport at the lowest cost to the destination point of APO with ZIP 96260-5479. Delivery is required within 84 days FOB destination, with zero tolerance for quantity variance, and inspection and acceptance occur at the point of delivery. The item is classified as a TYPE I (CODE S) under shelf-life requirement RS001, which prohibits extension beyond the 60-month limit. All technical and quality requirements referenced are governed by the DLA Master List, and the solicitation number SPE2DP-26-T-4448 governs procurement terms under a federal acquisition vehicle.

All Other Miscellaneous Chemical Product and Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

WATER FOR IRRIGATION, S

Solicitation # SPE2DP-26-T-4458

Water for Irrigation, Sterile, USP, is a sterile, distilled, nonpyrogenic solution intended exclusively for irrigation, washing, rinsing, and dilution purposes and is not for injection by any parenteral route. Each unit is a 1000 mL semi-rigid plastic container with a screw cap, available with or without a hanging device, and is packaged in cases of 12 units per package, the unit of issue. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), protected from freezing and excessive heat, and has a non-extendable shelf life of 36 months. It is regulated by the FDA and must be marked in compliance with the latest edition of Medical Marking Standard No. 1 and labeled according to MIL-STD-129. Packaging must adhere to DLA’s RP001 requirements and ASTM D3951 for non-hazardous materials, with DLA’s technical and quality requirements overriding any conflicting standards. The item is identified by NSN 6505-01-075-0679 and NDC 00338-0004-04, manufactured by Baxter Healthcare Corporation. The contract specifies delivery of two packages totaling 24 units, with delivery due within 20 days to two separate destinations: USS William P Lawrence DDG 110 and USS Zumwalt DDG 1000, FOB destination. Inspection and acceptance occur at the delivery point, with zero variance permitted in quantity. Shipping must use traceable transport methods, and parcel post is prohibited. All requirements, including those from the DLA Master List of Technical and Quality Requirements, must be strictly followed, and the solicitation, issued by the Department of Defense, has a response deadline of August 10, 2026, with a contract award anticipated in support of military medical supply needs.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

RINGER'S INJECTION, LAC

Solicitation # SPE2DP-26-T-4450

RINGER’S INJECTION, LACTATED, USP, 1000ML, in packs of 12 units per package, is procured under contract SPE2DP-26-T-4450 with a delivery requirement of 20 days FOB destination. The item is regulated by the FDA and requires prior confirmation by a product specialist through EBS referral, including full bidder and manufacturer details such as B. BRAUN MEDICAL INC, part number L7500, and NDC 00264-7750-00. Each unit must be sealed in a protective container and packed in commercial shipping containers suitable for safe transport via common carrier at the lowest cost. All packaging and labeling must comply with Medical Marking Standard No. 1, replacing MIL-STD-129, and must be marked according to the latest edition of MMS NO. 1, accessible via DLA’s website. The product has a non-extendable shelf life of 30 months and must be stored at or near room temperature (25°C), with brief exposure to 40°C permitted without degradation. Inspection and acceptance occur at the destination, with zero tolerance for quantity variance. The unit of issue is one package (PG), equal to 12 units, and the NSN is 6505013306267. Technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date. Delivery is to Gastonia, NC, and the contracting office is under the Department of Defense’s Medical Supply Chain.

Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE